Feb 2, 2026 08:01AM
Feb 2, 2026 08:00AM
Dec 18, 2025 04:05PM
Dec 18, 2025 04:05PM
Nov 6, 2025 04:15PM
Oct 9, 2025 08:00AM
Oct 9, 2025 08:00AM vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
Sep 15, 2025 08:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 04:15PM
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM
May 19, 2025 09:00AM vTv Therapeutics (VTVT) Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
May 19, 2025 09:00AM
May 15, 2025 04:01PM
May 15, 2025 12:00PM
May 15, 2025 12:00PM
Mar 20, 2025 05:35PM
Mar 17, 2025 08:30AM
Mar 17, 2025 08:30AM vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Dec 2, 2024 04:05PM
Nov 12, 2024 04:05PM
Aug 8, 2024 04:15PM
Jul 26, 2024 04:05PM
Jul 26, 2024 04:05PM
Jun 24, 2024 04:08PM
Jun 24, 2024 04:05PM vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
May 9, 2024 04:51PM
Mar 13, 2024 08:00AM
Mar 4, 2024 08:00AM
Mar 4, 2024 08:00AM
Mar 1, 2024 08:00AM
Feb 28, 2024 08:01AM
Feb 28, 2024 08:00AM vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
Nov 9, 2023 04:30PM
Nov 8, 2023 08:00AM
Nov 2, 2023 08:05AM
Nov 2, 2023 08:00AM
Nov 1, 2023 08:01AM
Nov 1, 2023 08:00AM
Aug 11, 2023 04:31PM vTv Therapeutics (VTVT) Reports Q2 Results
Aug 11, 2023 04:30PM
Jun 16, 2023 08:03AM
Jun 16, 2023 08:00AM
May 24, 2023 09:03AM
May 24, 2023 09:00AM
May 11, 2023 04:15PM
Mar 6, 2023 05:56PM vTv Therapeutics Announces 2022 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Dec 13, 2022 08:15AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All